Performance
LowHasn't fared well - amongst the low performers
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
LowProfitability and efficiency haven't been upto the mark
Entry point
AvgThe stock is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
—
—
—
Sun Pharma Advanced Research Company Limited is engaged in the research and experimental development on natural sciences and engineering (Pharmacy).
Customise key metrics, see detailed forecasts, download stock data and more
Pledged promoter holdings is insignificant
In last 3 months, mutual fund holding of the company has almost stayed constant
3 weeks ago•Business Standard
3 weeks ago•Free Press Journal
Sun Pharma Advanced Research Company Limited has submitted the Exchange a copy Srutinizers report of Annual General Meeting held on August 12, 2024. Further, the company has informed the Exchange regarding voting results. | Download
Sun Pharma Advanced Research Company Limited has submitted the Exchange a copy Srutinizers report of Annual General Meeting held on August 12, 2024. Further, the company has informed the Exchange regarding voting results. | Download
Sun Pharma Advanced Research Company Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on August 12, 2024 along with a copy of minutes. | Download
Sun Pharma Advanced Research Company Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on August 12, 2024 along with a copy of minutes. | Download
Total Promoter HoldingIncreasing promoter holding is considered good and reflects management’s positive view about the future outlook
In last 6 months, promoter holding in the company has almost stayed constant